Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 223

Results For "X"

9471 News Found

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
People | April 27, 2026

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D

His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research


Sun Pharma to acquire Organon in $11.75 billion all-cash deal
News | April 27, 2026

Sun Pharma to acquire Organon in $11.75 billion all-cash deal

Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally


Mandeep Singh Kumar, Shankha Banerjee  join NATHEALTH leadership team
Healthcare | April 27, 2026

Mandeep Singh Kumar, Shankha Banerjee join NATHEALTH leadership team

New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement


Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
Biopharma | April 27, 2026

Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26

Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science
News | April 27, 2026

Nihilent unveils nSEPIA Beta to turn emotional wellness into measurable science

nSEPIA aims to bring structure to an area long dominated by subjectivity


Zydus wins DCGI nod to launch Phase III trials of new anti-malarial drug Zintrodiazine
Clinical Trials | April 27, 2026

Zydus wins DCGI nod to launch Phase III trials of new anti-malarial drug Zintrodiazine

The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine


Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push
Drug Approval | April 27, 2026

Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push

The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA


Maarga Mind Care launches integrative day care program to bridge mental health recovery gap
Healthcare | April 27, 2026

Maarga Mind Care launches integrative day care program to bridge mental health recovery gap

New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery


Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments
Healthcare | April 27, 2026

Tata AIA launches ‘Shubh Health Criti’ blending life cover with wellness and investments

New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security